YCT-529

· YourChoice Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YCT-529, covering 2024-10-02 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males [Phase 1, Phase 2]